Australia markets closed

Lantern Pharma Inc. (LTRN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.28+0.46 (+7.90%)
At close: 04:00PM EDT
6.27 -0.01 (-0.16%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 67.57M
Enterprise value 29.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.89
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.42

Trading information

Stock price history

Beta (5Y monthly) 1.56
52-week change 321.94%
S&P500 52-week change 329.31%
52-week high 311.99
52-week low 32.38
50-day moving average 37.07
200-day moving average 34.78

Share statistics

Avg vol (3-month) 3348.02k
Avg vol (10-day) 392.21k
Shares outstanding 510.76M
Implied shares outstanding 610.76M
Float 87.86M
% held by insiders 114.75%
% held by institutions 122.77%
Shares short (30 Apr 2024) 4484.3k
Short ratio (30 Apr 2024) 42.23
Short % of float (30 Apr 2024) 45.12%
Short % of shares outstanding (30 Apr 2024) 44.50%
Shares short (prior month 28 Mar 2024) 4420.92k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-21.81%
Return on equity (ttm)-32.93%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -17.86M
Net income avi to common (ttm)-15.96M
Diluted EPS (ttm)-1.47
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.3M
Total cash per share (mrq)3.85
Total debt (mrq)234.47k
Total debt/equity (mrq)0.57%
Current ratio (mrq)16.18
Book value per share (mrq)3.82

Cash flow statement

Operating cash flow (ttm)-14.35M
Levered free cash flow (ttm)-8.7M